Final Thoughts on Chemistry for Cis-Dichlorobis(2,2′-bipyridine)ruthenium(II)

If you are interested in 15746-57-3, you can contact me at any time and look forward to more communication.Synthetic Route of 15746-57-3

Synthetic Route of 15746-57-3. Let’s face it, organic chemistry can seem difficult to learn. Especially from a beginner’s point of view. Like 15746-57-3, Name is Cis-Dichlorobis(2,2′-bipyridine)ruthenium(II). In a document type is Article, introducing its new discovery.

Ruthenium possesses several favorable properties suited to rational anticancer drug design when conjugation with the porphyrin moiety was accomplished through peripheral pyridyl rings. The ruthenium porphyrin conjugates are soluble at least moderately in aqueous solution and are thus suitable for biological investigations in particular for cytotoxicity and photocyotoxicity tests. In present study the compound 5,10,15,20 tetra pyridyl porphyrin coordinated to four [Ru (bipy)2 Cl]+ groups (meso-5,10,15,20 tetrakis {4(chloro-bis-bipyridyl ruthenium(II)) pyridyl} porphyrin) is synthesized by modified Alder method. This compound is characterized by UV-Visible Spectroscopy, FT-IR Spectroscopy, 1H-NMR spectroscopy, Fluorescence Spectroscopy and Cyclic Voltametry. In-Vitro anticancer activity of the compounds have been evaluated by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay method. The results show that the compound is cytotoxic against human lymphoma cancer cells.

If you are interested in 15746-57-3, you can contact me at any time and look forward to more communication.Synthetic Route of 15746-57-3

Reference:
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI